PMID- 38077069 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240412 DP - 2023 Nov 30 TI - Loss of Slc35a2 alters development of the mouse cerebral cortex. LID - 2023.11.29.569243 [pii] LID - 10.1101/2023.11.29.569243 [doi] AB - Brain somatic variants in SLC35A2 are associated with clinically drug-resistant epilepsy and developmental brain malformations, including mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). SLC35A2 encodes a uridine diphosphate galactose translocator that is essential for protein glycosylation; however, the neurodevelopmental mechanisms by which SLC35A2 disruption leads to clinical and histopathological features remain unspecified. We hypothesized that focal knockout (KO) or knockdown (KD) of Slc35a2 in the developing mouse cortex would disrupt cerebral cortical development through altered neuronal migration and cause changes in network excitability. We used in utero electroporation (IUE) to introduce CRISPR/Cas9 and targeted guide RNAs or short-hairpin RNAs to achieve Slc35a2 KO or KD, respectively, during early corticogenesis. Following Slc35a2 KO or KD, we observed disrupted radial migration of transfected neurons evidenced by heterotopic cells located in lower cortical layers and in the sub-cortical white matter. Slc35a2 KO in neurons did not induce changes in oligodendrocyte number, suggesting that the oligodendroglial hyperplasia observed in MOGHE originates from distinct cell autonomous effects. Spontaneous seizures were not observed, but intracranial EEG recordings after focal KO showed a reduced seizure threshold following pentylenetetrazol injection. These results demonstrate that Slc35a2 KO or KD in vivo disrupts corticogenesis through altered neuronal migration. FAU - Elziny, Soad AU - Elziny S AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Sran, Sahibjot AU - Sran S AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. FAU - Yoon, Hyojung AU - Yoon H AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. FAU - Corrigan, Rachel R AU - Corrigan RR AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. FAU - Page, John AU - Page J AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Ringland, Amanda AU - Ringland A AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. FAU - Lanier, Anna AU - Lanier A AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. FAU - Lapidus, Sara AU - Lapidus S AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Foreman, James AU - Foreman J AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Heinzen, Erin L AU - Heinzen EL AD - Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy and Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. FAU - Iffland, Philip AU - Iffland P AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Crino, Peter B AU - Crino PB AD - Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA. FAU - Bedrosian, Tracy A AU - Bedrosian TA AD - Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. AD - Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA. LA - eng GR - R01 NS094596/NS/NINDS NIH HHS/United States GR - R01 NS115017/NS/NINDS NIH HHS/United States GR - R01 NS129784/NS/NINDS NIH HHS/United States PT - Preprint DEP - 20231130 PL - United States TA - bioRxiv JT - bioRxiv : the preprint server for biology JID - 101680187 PMC - PMC10705455 OTO - NOTNLM OT - CRISPR OT - cerebral cortex OT - cortical dysplasia OT - glycosylation OT - short-hairpin RNA COIS- Competing Interest Statement The authors have no competing interests to declare. EDAT- 2023/12/11 12:43 MHDA- 2023/12/11 12:44 PMCR- 2023/12/08 CRDT- 2023/12/11 06:24 PHST- 2023/12/11 12:43 [pubmed] PHST- 2023/12/11 12:44 [medline] PHST- 2023/12/11 06:24 [entrez] PHST- 2023/12/08 00:00 [pmc-release] AID - 2023.11.29.569243 [pii] AID - 10.1101/2023.11.29.569243 [doi] PST - epublish SO - bioRxiv [Preprint]. 2023 Nov 30:2023.11.29.569243. doi: 10.1101/2023.11.29.569243.